Retatrutide
What retatrutide is
Retatrutide is a triple receptor agonist: a single peptide with activity at three separate receptors, GIP, GLP-1 and glucagon. That third component is what distinguishes it from the dual agonists. GLP-1 agonists act on one receptor, tirzepatide acts on two, and retatrutide adds glucagon receptor activity to the same molecule.
It is an investigational compound. Retatrutide holds no marketing authorisation in the UK, the EU or the United States, and remains in clinical development rather than licensed use. Material supplied here is for laboratory and research purposes only.
How it differs from tirzepatide and semaglutide
| Compound | Receptors | Class |
|---|---|---|
| Semaglutide | GLP-1 | Single agonist |
| Tirzepatide | GIP + GLP-1 | Dual agonist |
| Retatrutide | GIP + GLP-1 + glucagon | Triple agonist |
The receptor count is not a ranking of potency, it describes mechanism. Glucagon receptor activity is the meaningful structural difference in retatrutide, and it is the reason its pharmacology is studied separately rather than treated as an extension of the GLP-1 class.
Presentation
Supplied by Quanta Pharma as a lyophilised powder in a sealed vial, with bacteriostatic water included. Lyophilised means freeze-dried under vacuum: the water has been removed, leaving a solid cake or a thin film at the base of the vial. Both appearances are normal and the quantity is confirmed by weight at manufacture.
The vial requires reconstitution. The included bacteriostatic water is the diluent, and its 0.9 percent benzyl alcohol content is what allows more than one withdrawal from the same vial.
The same compound is also available as a pre-filled SerenQ pen, which arrives as a made-up solution and needs no reconstitution at all.
Reconstitution
Bring the vial to room temperature first. Swab both stoppers, draw the bacteriostatic water, and introduce it against the inside wall of the vial so it runs down the glass rather than striking the powder. A jet fired directly into the cake shears the peptide, and it is the most common handling error with lyophilised material.
Allow it to dissolve on its own, swirling gently if slow. Never shake. Agitation denatures peptides and the foam it produces indicates damage rather than mixing. The finished solution should be clear and colourless. Cloudiness, visible strands or material that will not go into solution means the vial should not be used.
Concentration is total peptide divided by diluent volume. A 30mg vial with 3ml added gives 10mg/ml, so 10 units on a U-100 insulin syringe carries 1000mcg. The same vial with 6ml gives 5mg/ml and those 10 units carry 500mcg. The vial has not changed, only the arithmetic. Using more diluent spreads the material across more syringe units, which makes small measurements proportionally more accurate.
Storage
Sealed and lyophilised, store at 2 to 8 degrees Celsius away from light. Dry material is stable for a long period because hydrolysis, the primary degradation route, requires water to proceed.
Once reconstituted, refrigerate at 2 to 8 degrees, keep upright and out of light, and do not freeze. Ice crystals forming through a solution physically shear peptide chains, and each freeze-thaw cycle compounds the damage. A solution frozen and thawed twice can look entirely clear while having lost much of its activity.
Bacteriostatic water is commonly specified at 28 days from first puncture. In practice that figure often governs before the peptide's own chemical stability does, so mark the vial with the date it was first punctured.
Batch testing
Every Quanta Pharma batch is HPLC tested. High-performance liquid chromatography drives a sample under pressure through a packed column, separating it into its components. The resulting chromatogram shows the main peak alongside any impurities, and purity is expressed as main peak area against total area.
A purity figure only means something if the batch identifier on the report matches the batch in front of you. Check that before relying on it.
Frequently asked
Is retatrutide the same as Mounjaro or Wegovy? No. Mounjaro is tirzepatide and Wegovy is semaglutide, both licensed medicines. Retatrutide is a different molecule and holds no marketing authorisation anywhere.
What is the difference between the vial and the pen? The vial is lyophilised powder requiring reconstitution, and you choose the concentration. The pen arrives as a made-up solution at a fixed concentration and is dosed by dialling units, which removes the reconstitution step and the arithmetic.
Why does it come with bacteriostatic water? Because the vial needs a diluent, and the preservative in bacteriostatic water permits repeated withdrawals. Plain sterile water has no preservative and would make the vial single use.
Does it need refrigerating on arrival? Sealed lyophilised vials should go to 2 to 8 degrees Celsius. Brief periods at room temperature in transit are normal and do not meaningfully affect dry material.
Supplied strictly for laboratory and research purposes. Not a medicine, and not intended for human or veterinary use, diagnosis, treatment or therapeutic application.